Evidence map›Paper›PMID 36879321›Full record

ArticleJournal of neuroinflammation2023

Microglia specific deletion of miR-155 in Alzheimer's disease mouse models reduces amyloid-β pathology but causes hyperexcitability and seizures.

Macarena S Aloi, Katherine E Prater, Raymond E A Sánchez, Asad Beck, Jasmine L Pathan, Stephanie Davidson, Angela Wilson, C Dirk Keene, Horacio de la Iglesia, Suman Jayadev and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Macarena S AloiDepartment of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, WA, 98195, USA.
Katherine E PraterDepartment of Neurology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Raymond E A SánchezDepartment of Biology, University of Washington, Seattle, WA, 98109, USA.
Asad BeckDepartment of Biology, University of Washington, Seattle, WA, 98109, USA.
Jasmine L PathanDepartment of Neurology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Stephanie DavidsonDepartment of Neurology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Angela WilsonDepartment of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, WA, 98195, USA.
C Dirk KeeneDepartment of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, WA, 98195, USA.
Horacio de la IglesiaDepartment of Biology, University of Washington, Seattle, WA, 98109, USA.
Suman JayadevDepartment of Neurology, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Gwenn A GardenDepartment of Neurology, University of Washington School of Medicine, Seattle, WA, 98195, USA. gagarden@email.unc.edu.
University of Washington · USUniversity of North Carolina at Chapel Hill · US

Funding

University of Washington Alzheimer's Disease Research CenterP30AG066509 · NIA · UNIVERSITY OF WASHINGTON · PI Amanda D. Boyd · 2020 to 2026
$29.0M
Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's DiseaseT32AG052354 · NIA · UNIVERSITY OF WASHINGTON · PI Brian C. Kraemer, ELAINE R. PESKIND · 2016 to 2026
$6.7M
MicroRNA regulation of central nervous system and systemic inflammation in ADRF1AG051437 · NIA · UNIVERSITY OF WASHINGTON · PI GARDEN, GWENN A, JAYADEV, SUMAN · 2015 to 2019
$2.6M
Role of GABA on circadian and homeostatic regulation of sleepR01NS094211 · NINDS · UNIVERSITY OF WASHINGTON · PI DE LA IGLESIA, HORACIO O · 2015 to 2018
$1.4M
Proliferation and differentiation of adult microglia progenitor cellsR21NS096334 · NINDS · UNIVERSITY OF WASHINGTON · PI GARDEN, GWENN A · 2016 to 2017
$426k
Howard Hughes Medical Institute Gilliam Fellowship for Advanced StudiesNIA NIH HHS 5T32-AG052354-02NIA NIH HHS P30 AG066509NIA NIH HHS RF1 AG051437NIA NIH HHS T32 AG052354NIA NIH HHS T32AG052354NIH HHS R01 AG051437-01NIH HHS R01-NS094211NIH HHS R21 NS096334-01A1NINDS NIH HHS R01 NS094211NINDS NIH HHS R21 NS096334
6 · The paper itself

Abstract

Alzheimer's Disease (AD) is characterized by the accumulation of extracellular amyloid-β (Aβ) as well as CNS and systemic inflammation. Microglia, the myeloid cells resident in the CNS, use microRNAs to rapidly respond to inflammatory signals. MicroRNAs (miRNAs) modulate inflammatory responses in microglia, and miRNA profiles are altered in Alzheimer's disease (AD) patients. Expression of the pro-inflammatory miRNA, miR-155, is increased in the AD brain. However, the role of miR-155 in AD pathogenesis is not well-understood. We hypothesized that miR-155 participates in AD pathophysiology by regulating microglia internalization and degradation of Aβ. We used CX3CR1

Indexed as

Alzheimer DiseaseMicroRNAsAmyloid beta-PeptidesAnimalsDisease Models, AnimalMiceMicrogliaSeizuresAmyloid beta-PeptidesMicroRNAsMirn155 microRNA, mouseAlzheimer’s diseaseEpilepsyInducible knock-outMicrogliamiR-155Mouse models

Identifiers

PMID36879321
PMCPMC9990295
OpenAlexW4323347297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.